Early to late explantation of Hydrus microstent MIGS device: A case series

Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Neha Sachdeva, Lynn W. Sun, Jonathan Young, Aiyin Chen
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993624001154
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846117827112599552
author Neha Sachdeva
Lynn W. Sun
Jonathan Young
Aiyin Chen
author_facet Neha Sachdeva
Lynn W. Sun
Jonathan Young
Aiyin Chen
author_sort Neha Sachdeva
collection DOAJ
description Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation. Here we report four such cases and their associated challenges. We also highlight the importance of early recognition of post-operative complications for ease of implant removal. Observations: Case 1: A 75-year-old female patient was referred for chronic granulomatous anterior uveitis with cystoid macular edema (CME) and uncontrolled IOP in the left eye after cataract extraction with Hydrus implantation. On gonioscopy, the implant was occluded and embedded in the iris. The patient underwent removal of the Hydrus implant 10 months after the initial surgery with canaloplasty to control IOP.Case 2: A 71-year-old male patient on dual anti-platelet developed intraoperative hyphema during cataract extraction with Hydrus microstent in the right eye. Post-operatively, clopidogrel was stopped, but hyphema persisted with uncontrolled IOP. The Hydrus was noted to be syneched against the iris face. The patient underwent anterior chamber washout with Hydrus explantation and Ahmed glaucoma valve implantation 16 days after the first surgery.Case 3: A 76-year-old patient developed persistent granulomatous anterior uveitis in the left eye after cataract extraction with Hydrus microstent. On gonioscopy, the Hydrus ostium was seen resting on the iris without occlusion, and the patient underwent Hydrus removal with nasal goniotomy 3 months after initial surgery.Case 4: A 63-year-old patient underwent cataract extraction with endoscopic cyclophotocoagulation and a complex Hydrus microstent implantation requiring multiple attempts. Eleven months later, the patient was found to have uveitis-glaucoma-hyphema syndrome and macular edema, and the Hydrus was noted to be insufficiently inserted and posteriorly rotated with contact against the iris. The Hydrus was explanted, and nasal goniotomy was performed. Conclusions and importance: Hydrus microstents that are malpositioned can result in persistent uveitis-glaucoma-hyphema syndrome. Explantation between 2 weeks and 11 months successfully resolved post-operative uveitis and hyphema, but all cases required additional glaucoma-hyphema syndrome. Early recognition is important since late removal was more challenging due to the implant becoming embedded in the iris.
format Article
id doaj-art-a21ed2aa626d42c7bec350011f03cf97
institution Kabale University
issn 2451-9936
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj-art-a21ed2aa626d42c7bec350011f03cf972024-12-18T08:50:24ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362024-12-0136102105Early to late explantation of Hydrus microstent MIGS device: A case seriesNeha Sachdeva0Lynn W. Sun1Jonathan Young2Aiyin Chen3Casey Eye Institute, Oregon Health and Science University, Portland, OR, USACasey Eye Institute, Oregon Health and Science University, Portland, OR, USANVISION Eye Center, Tigard, Oregon, USACasey Eye Institute, Oregon Health and Science University, Portland, OR, USA; Corresponding author. 515 SW Campus Drive, Portland, OR, 97239, USA.Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation. Here we report four such cases and their associated challenges. We also highlight the importance of early recognition of post-operative complications for ease of implant removal. Observations: Case 1: A 75-year-old female patient was referred for chronic granulomatous anterior uveitis with cystoid macular edema (CME) and uncontrolled IOP in the left eye after cataract extraction with Hydrus implantation. On gonioscopy, the implant was occluded and embedded in the iris. The patient underwent removal of the Hydrus implant 10 months after the initial surgery with canaloplasty to control IOP.Case 2: A 71-year-old male patient on dual anti-platelet developed intraoperative hyphema during cataract extraction with Hydrus microstent in the right eye. Post-operatively, clopidogrel was stopped, but hyphema persisted with uncontrolled IOP. The Hydrus was noted to be syneched against the iris face. The patient underwent anterior chamber washout with Hydrus explantation and Ahmed glaucoma valve implantation 16 days after the first surgery.Case 3: A 76-year-old patient developed persistent granulomatous anterior uveitis in the left eye after cataract extraction with Hydrus microstent. On gonioscopy, the Hydrus ostium was seen resting on the iris without occlusion, and the patient underwent Hydrus removal with nasal goniotomy 3 months after initial surgery.Case 4: A 63-year-old patient underwent cataract extraction with endoscopic cyclophotocoagulation and a complex Hydrus microstent implantation requiring multiple attempts. Eleven months later, the patient was found to have uveitis-glaucoma-hyphema syndrome and macular edema, and the Hydrus was noted to be insufficiently inserted and posteriorly rotated with contact against the iris. The Hydrus was explanted, and nasal goniotomy was performed. Conclusions and importance: Hydrus microstents that are malpositioned can result in persistent uveitis-glaucoma-hyphema syndrome. Explantation between 2 weeks and 11 months successfully resolved post-operative uveitis and hyphema, but all cases required additional glaucoma-hyphema syndrome. Early recognition is important since late removal was more challenging due to the implant becoming embedded in the iris.http://www.sciencedirect.com/science/article/pii/S2451993624001154Hydrus microstentSurgical complicationExplantationMIGSUGH
spellingShingle Neha Sachdeva
Lynn W. Sun
Jonathan Young
Aiyin Chen
Early to late explantation of Hydrus microstent MIGS device: A case series
American Journal of Ophthalmology Case Reports
Hydrus microstent
Surgical complication
Explantation
MIGS
UGH
title Early to late explantation of Hydrus microstent MIGS device: A case series
title_full Early to late explantation of Hydrus microstent MIGS device: A case series
title_fullStr Early to late explantation of Hydrus microstent MIGS device: A case series
title_full_unstemmed Early to late explantation of Hydrus microstent MIGS device: A case series
title_short Early to late explantation of Hydrus microstent MIGS device: A case series
title_sort early to late explantation of hydrus microstent migs device a case series
topic Hydrus microstent
Surgical complication
Explantation
MIGS
UGH
url http://www.sciencedirect.com/science/article/pii/S2451993624001154
work_keys_str_mv AT nehasachdeva earlytolateexplantationofhydrusmicrostentmigsdeviceacaseseries
AT lynnwsun earlytolateexplantationofhydrusmicrostentmigsdeviceacaseseries
AT jonathanyoung earlytolateexplantationofhydrusmicrostentmigsdeviceacaseseries
AT aiyinchen earlytolateexplantationofhydrusmicrostentmigsdeviceacaseseries